Source: HJ Cha et al, Evolutionarily Repurposed Networks Reveal the Well-Known Antifungal Drug Thiabendazole to Be a Novel Vascular Disrupting Agent, PLoS Biol 10(8): e1001379. Doi:10.1371/journal.pbio.1001379
A recent paper published in the journal PLOS Biology describes a study in which scientists tested the effect of thiabendazole (TBZ), a compound used for many years as an anti-fungal drug, on tumor growth in mice. Tumors typically begin as small clusters of cells that grow rapidly and uncontrollably into larger masses. In an experiment described in this paper, human tumor cells were implanted under the skin of mice in an area where the tumor growth could be observed visually. These mice are an experimental system that can be used to test the effects of TBZ on a tumor in a living organism. To be administered to a mouse, TBZ must be dissolved in a solvent called DMSO (dimethylsulfoxide) and injected.
In the experiment described in this paper, the scientists allowed the tumors to become established and reach a designated size. When the tumors were large enough, the mice were injected daily with 1 mg TBZ dissolved in DMSO, or injected with DMSO only, for 26 days. Tumor growth was monitored over time, and the tumor volume in mm3 was calculated. At the end of the experiment, the tumors were removed and weighed.
Select all that apply. How was tumor growth measured in this study?
Select one or more of the following: